Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 183
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #227: A Closer Look at Compass’ 6-Month Data; AtaiBeckley Deal Update; ‘Rysanso’ Brand MDMA?
Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch
Psychedelic Policy Briefing: Week of July 6, 2026
Psychedelics Today at the Aspen Psychedelic Symposium
The Framework Gap in Psychedelic Practice: An Introduction to the 8-Circuit Model of Consciousness
COMPASS Pathways presents largest ever study of psilocybin therapy, at American...
Incannex announces positive results from phase 2 clinical trial investigating the...
PT330 – Dick Simon – Researching Ethnobotanical Efficacy and the Search...
Exploring Ketamine’s Antimicrobial Effects & Fungal Sources: Part 2
PT329 – Dr. Scott Shannon – The Board of Psychedelic Medicine...
Psychedelic Bulletin #107 – Call for Proposals: Opinions Column; How to...
PT328 – Courtney Watson, LMFT – Ancestral Veneration and Psychedelic-Assisted Therapy...
Exploring Ketamine’s Antimicrobial Effects & Fungal Sources: Part 1
PT327 – Rick Doblin, Ph.D. – Confronting Abuse in Clinical Trials...
Psychedelic Bulletin #106 – DMT Study Skips Set and Setting; Cybin...
Load more